Articles

Toshiba CT Myocardial Perfusion Advanced Visualization CT Systems

The U.S. Food and Drug Administration (FDA) cleared Toshiba’s CT Myocardial Perfusion capability. Available on Toshiba’s Aquilion One and Aquilion OneVison Edition ...

February 28, 2014 — Igor Efimov, Ph.D., from the School of Engineering & Applied Science at Washington University in St. Louis, and an international team of biomedical engineers and materials...

The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) 2013 offers many new insights about the latest cardiovascular technologies and treatment techniques. These...

Siemens Healthcare will introduce version VA30 of its routine 3-D and advanced reading software syngo.via at the ...

cath lab tct advanced visualization hybrid or philips realview holographic 3-D

Philips and RealView Imaging Ltd. have completed a clinical study that demonstrated the feasibility of using an innovative live 3-D holographic ...

FDA regulates apps, mobile devices

In an effort to guide regulation of mobile medical apps, the U.S. Food and Drug Administration (FDA) issued a final guidance document for developers of mobile medical apps. 

The use of 3-D echo can help improve the accuracy and reproducibility of cardiac quantification. The technology has the advantage of removing the inter-operator variability by imaging whole volume...

 Medtronic Inc. announced market release of the CardioGuide Implant System, a novel real-time navigation system for cardiac resynchronization therapy pacemakers and defibrillators (CRT-P and...

Toshiba, activation imaging, ACC, 2013

This is a roundup of some of the DAIC editor's choice of the most innovative new technologies showcased at ACC 2013, including products in the areas of interventional cardiology, patient...

RealView's 3-D holographic projection of a heart

The annual Transcatheter Cardiovascular Therapeutics (TCT) meeting brings many cutting-edge technologies to the forefront during its five days of clinical sessions. This is my editor’s choice of...